Home/Filings/4/0001209191-07-054913
4//SEC Filing

ATHENAHEALTH INC 4

Accession 0001209191-07-054913

CIK 0001131096operating

Filed

Sep 24, 8:00 PM ET

Accepted

Sep 25, 4:00 PM ET

Size

23.2 KB

Accession

0001209191-07-054913

Insider Transaction Report

Form 4
Period: 2007-09-25
Transactions
  • Sale

    Common Stock

    2007-09-25$18.00/sh290,000$5,220,0001,160,944 total(indirect: See Footnote.)
  • Sale

    Common Stock

    2007-09-25$18.00/sh383,000$6,894,0001,532,246 total(indirect: See Footnote.)
  • Conversion

    Common Stock

    2007-09-25+1,915,2461,915,246 total(indirect: See Footnote.)
  • Conversion

    Series C preferred stock

    2007-09-251,915,2460 total(indirect: See Footnote.)
    From: 2007-09-25Common Stock (1,915,246 underlying)
  • Conversion

    Series D preferred stock

    2007-09-251,450,9440 total(indirect: See Footnote.)
    From: 2007-09-25Common Stock (1,450,944 underlying)
  • Conversion

    Common Stock

    2007-09-25+1,450,9441,450,944 total(indirect: See Footnote.)
Transactions
  • Sale

    Common Stock

    2007-09-25$18.00/sh383,000$6,894,0001,532,246 total(indirect: See Footnote.)
  • Conversion

    Common Stock

    2007-09-25+1,915,2461,915,246 total(indirect: See Footnote.)
  • Sale

    Common Stock

    2007-09-25$18.00/sh290,000$5,220,0001,160,944 total(indirect: See Footnote.)
  • Conversion

    Series C preferred stock

    2007-09-251,915,2460 total(indirect: See Footnote.)
    From: 2007-09-25Common Stock (1,915,246 underlying)
  • Conversion

    Series D preferred stock

    2007-09-251,450,9440 total(indirect: See Footnote.)
    From: 2007-09-25Common Stock (1,450,944 underlying)
  • Conversion

    Common Stock

    2007-09-25+1,450,9441,450,944 total(indirect: See Footnote.)
Transactions
  • Conversion

    Common Stock

    2007-09-25+1,450,9441,450,944 total(indirect: See Footnote.)
  • Conversion

    Series D preferred stock

    2007-09-251,450,9440 total(indirect: See Footnote.)
    From: 2007-09-25Common Stock (1,450,944 underlying)
  • Conversion

    Common Stock

    2007-09-25+1,915,2461,915,246 total(indirect: See Footnote.)
  • Sale

    Common Stock

    2007-09-25$18.00/sh290,000$5,220,0001,160,944 total(indirect: See Footnote.)
  • Conversion

    Series C preferred stock

    2007-09-251,915,2460 total(indirect: See Footnote.)
    From: 2007-09-25Common Stock (1,915,246 underlying)
  • Sale

    Common Stock

    2007-09-25$18.00/sh383,000$6,894,0001,532,246 total(indirect: See Footnote.)
CLARKE JOHN K
10% Owner
Transactions
  • Sale

    Common Stock

    2007-09-25$18.00/sh383,000$6,894,0001,532,246 total(indirect: See Footnote.)
  • Conversion

    Series C preferred stock

    2007-09-251,915,2460 total(indirect: See Footnote.)
    From: 2007-09-25Common Stock (1,915,246 underlying)
  • Conversion

    Common Stock

    2007-09-25+1,915,2461,915,246 total(indirect: See Footnote.)
  • Conversion

    Common Stock

    2007-09-25+1,450,9441,450,944 total(indirect: See Footnote.)
  • Conversion

    Series D preferred stock

    2007-09-251,450,9440 total(indirect: See Footnote.)
    From: 2007-09-25Common Stock (1,450,944 underlying)
  • Sale

    Common Stock

    2007-09-25$18.00/sh290,000$5,220,0001,160,944 total(indirect: See Footnote.)
Transactions
  • Conversion

    Common Stock

    2007-09-25+1,450,9441,450,944 total(indirect: See Footnote.)
  • Conversion

    Common Stock

    2007-09-25+1,915,2461,915,246 total(indirect: See Footnote.)
  • Conversion

    Series D preferred stock

    2007-09-251,450,9440 total(indirect: See Footnote.)
    From: 2007-09-25Common Stock (1,450,944 underlying)
  • Sale

    Common Stock

    2007-09-25$18.00/sh290,000$5,220,0001,160,944 total(indirect: See Footnote.)
  • Conversion

    Series C preferred stock

    2007-09-251,915,2460 total(indirect: See Footnote.)
    From: 2007-09-25Common Stock (1,915,246 underlying)
  • Sale

    Common Stock

    2007-09-25$18.00/sh383,000$6,894,0001,532,246 total(indirect: See Footnote.)
Transactions
  • Sale

    Common Stock

    2007-09-25$18.00/sh383,000$6,894,0001,532,246 total(indirect: See Footnote.)
  • Conversion

    Series C preferred stock

    2007-09-251,915,2460 total(indirect: See Footnote.)
    From: 2007-09-25Common Stock (1,915,246 underlying)
  • Conversion

    Series D preferred stock

    2007-09-251,450,9440 total(indirect: See Footnote.)
    From: 2007-09-25Common Stock (1,450,944 underlying)
  • Conversion

    Common Stock

    2007-09-25+1,450,9441,450,944 total(indirect: See Footnote.)
  • Conversion

    Common Stock

    2007-09-25+1,915,2461,915,246 total(indirect: See Footnote.)
  • Sale

    Common Stock

    2007-09-25$18.00/sh290,000$5,220,0001,160,944 total(indirect: See Footnote.)
Footnotes (5)
  • [F1]Cardinal Health Partners, L.P. is the record holder of the securities. As the general partner of Cardinal Health Partners, L.P., Cardinal Health Partners Management, L.L.C. may be deemed a beneficial owner of the securities. In their capacities as managing members of Cardinal Health Partners Management, L.L.C., each of John K. Clarke, Brandon H. Hull, Lisa Skeete Tatum and John J. Park may be deemed to be beneficial owners of the securities. Each Joint Filer, other than Cardinal Health Partners, L.P., expressly disclaims beneficial ownership of the securities, except to the extent of its pecuniary interest therein, if any.
  • [F2]CHP II, L.P. is the record holder of the securities. As the general partner of CHP II, L.P., CHP II Management, L.L.C. may be deemed a beneficial owner of the securities. In their capacities as managing members of CHP II Management, L.L.C., each of John K. Clarke, Brandon H. Hull, Lisa Skeete Tatum and John J. Park may be deemed to be beneficial owners of the securities. Each Joint Filer, other than CHP II, L.P., expressly disclaims beneficial ownership of the securities, except to the extent of its pecuniary interest therein, if any.
  • [F3]Shares sold pursuant to the initial public offering of common stock of athenahealth, Inc. through both the secondary offering and exercise of the over-allotment option by the underwriters.
  • [F4]These shares automatically converted into common stock on a one-for-one basis upon the closing of the Issuer's initial public offering of common stock.
  • [F5]The preferred stock has no expiration date.

Issuer

ATHENAHEALTH INC

CIK 0001131096

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001131096

Filing Metadata

Form type
4
Filed
Sep 24, 8:00 PM ET
Accepted
Sep 25, 4:00 PM ET
Size
23.2 KB